Low-grade gliomas: management issues.
Low-grade gliomas are relatively rare tumors. The optimal management of these tumors remains to be defined and has some controversies associated with it. In this review, we present the data that is available to date and some of the issues that exist in treating these tumors.
Duran
Isis
I
Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Abbott Hall, Department of Neurology, Room 1115, Chicago, IL 60611, USA. iduran004@md.northwestern.edu
Raizer
Jeffrey J
JJ
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome